3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
5
Phase 1
4
Phase 2/3
2
Phase 1/2
2
Phase 3
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
46
Myeloid
5
Lymphoid
3
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
Epoetin Alfa
27
Darbepoetin alfa
13
Cytarabine
9
Dalteparin
8
Rivaroxaban
7
Daunorubicin
7
apixaban
6
Etoposide
6
Methotrexate
5
Idarubicin
5
Heparin, Low-Molecular-Weight
5
Cyclophosphamide
5
emicizumab
4
Tinzaparin
4
Thioguanine
4
Mitoxantrone
4
Granulocyte Colony-Stimulating Factor
4
Filgrastim
4
Enoxaparin
4
pegfilgrastim
3
hetrombopag
3
epoetin beta
3
Saline Solution
3
Radiotherapy
3
Hydrocortisone
3
Erythropoietin
3
Dexamethasone
3
Aspirin
3
Asparaginase
3
telapristone acetate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Azacitidine
×
Classical hematology
×
Clear all
NCT04173533
2024-05-14
AMADEUS
University of Birmingham
Phase 3
Active not recruiting
326 enrolled